AIMC Topic: Lamivudine

Clear Filters Showing 1 to 4 of 4 articles

Rapid simultaneous analysis of anti human immunodeficiency virus drugs in pharmaceutical formulation by smart spectrophotometry based on multivariate calibration and least squares support vector machine methods.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy Dec 31, 2022
In this study, two chemometrics methods, including partial least squares regression (PLS) and least squares support vector machine (LS-SVM) were applied for the simultaneous determination of zidovudine (ZDV) and lamivudine (LMV) in synthetic mixtures...
Lamivudine HIV Support Vector Machine Least-Squares Analysis Spectrophotometry Zidovudine Drug Compounding Calibration
View on PubMed DOI

Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases Dec 26, 2017
OBJECTIVE: To investigate the long-term incidence and predictors for hepatitis B surface antigen (HBsAg) loss after nucleoside analogue therapy.
Hepatitis B Surface Antigens Hepatitis B e Antigens Guanine Lamivudine Hepatitis B, Chronic Treatment Outcome Humans Incidence Antiviral Agents Hepatitis B virus Genotype Male Middle Aged Female Adult
View on PubMed DOI

Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.

HIV medicine Aug 26, 2015
OBJECTIVES: To compare the efficacy, in current clinical practice, of first regimens containing abacavir with lamivudine (ABC/3TC) or tenofovir with emtricitabine (TDF/FTC) in patients with baseline viral load ≥100,000 HIV-1 RNA copies/mL.
Female Male Prospective Studies Viral Load Lamivudine Risk Assessment HIV Infections Humans France Propensity Score Treatment Failure Dideoxynucleosides Emtricitabine Tenofovir Drug Therapy, Combination
View on PubMed DOI

Efficacy and Tolerability of Tenofovir/Lamivudine/Dolutegravir among Antiretroviral Therapy Naive Human Immunodeficiency Virus Infected Patients of a Tertiary Care Center in Eastern India.

The Journal of the Association of Physicians of India Sep 1, 2023
BACKGROUND: Although many drug regimens have been used in the treatment of human immunodeficiency virus (HIV) infection, the National AIDS Control Organization (NACO) of India recommends the use of a fixed-dose combination of tenofovir/lamivudine/dol...
Heterocyclic Compounds, 3-Ring India Piperazines CD4 Lymphocyte Count Treatment Outcome Tertiary Care Centers Anti-HIV Agents Oxazines Pyridones Tenofovir Lamivudine Drug Combinations Longitudinal Studies Male Middle Aged HIV Infections Viral Load Female Humans Adult
View on PubMed DOI
Popular Topics
Recent Journals